Cambridge Healthtech Institute’s Inaugural
Immunotherapy for COVID-19
Vaccine and Biotherapeutic Development for SARS-CoV-2
October 8, 2020
In response to the urgent need for vaccines and biotherapeutics for the novel coronavirus, Cambridge Healthtech Institute is adding a new track dedicated to COVID-19 to our Immuno-Oncology Summit that aims to facilitate innovation and collaboration in
immunotherapy approaches to control the cytokine storm, develop novel antibody biotherapeutics and vaccines, and understand the immune response mechanisms.